1. Home
  2. CPRX
  3. CPRX News

Latest Catalyst Pharmaceuticals Inc. (CPRX) News on March 29, 2025

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win
CPRX

Investor's Business Daily

2 days ago

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’
CPRX

Insider Monkey

2 days ago

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’

CPRX

Argus Research

4 days ago

CPRX: Raising target price to $27.00

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business
CPRX

Simply Wall St.

4 days ago

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?
CPRX

Zacks

4 days ago

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
CPRX

Zacks

12 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?
CPRX

Insider Monkey

15 days ago

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative
CPRX

Simply Wall St.

24 days ago

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative

CPRX

Argus Research

25 days ago

CPRX: Raising target price to $24.00

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
CPRX

GlobeNewswire

25 days ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
CPRX

Simply Wall St.

a month ago

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
CPRX

GuruFocus.com

a month ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today
CPRX

Motley Fool

a month ago

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
CPRX

Zacks

a month ago

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates
CPRX

Zacks

a month ago

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates

CPRX

Associated Press Finance

a month ago

Catalyst: Q4 Earnings Snapshot

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
CPRX

GlobeNewswire

a month ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings
CPRX

GuruFocus.com

a month ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings

CPRX

Argus Research

a month ago

CPRX: Rating increased to a BUY

CPRX

Argus Research

a month ago

CPRX: What does Argus have to say about CPRX?

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90
CPRX

Investor's Business Daily

a month ago

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90

Incyte Stock Sees Relative Strength Rating Rise To 71
CPRX

Investor's Business Daily

a month ago

Incyte Stock Sees Relative Strength Rating Rise To 71

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%
CPRX

Simply Wall St.

a month ago

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
CPRX

GlobeNewswire

a month ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

CPRX

Argus Research

2 months ago

CPRX: What does Argus have to say about CPRX?

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry
CPRX

Investor's Business Daily

2 months ago

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

Harmony Biosciences Stock Scores 80-Plus RS Rating
CPRX

Investor's Business Daily

2 months ago

Harmony Biosciences Stock Scores 80-Plus RS Rating

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
CPRX

Zacks

2 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
CPRX

Zacks

2 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
CPRX

Zacks

2 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies
CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
CPRX

Zacks

2 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

CPRX

Argus Research

2 months ago

CPRX: Raising target price to $24.00

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
CPRX

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

BeiGene Stock Meets 80-Plus RS Rating Benchmark
CPRX

Investor's Business Daily

2 months ago

BeiGene Stock Meets 80-Plus RS Rating Benchmark

CPRX

Argus Research

2 months ago

CPRX: Raising target price to $23.00

BridgeBio Pharma Stock Earns 87 RS Rating
CPRX

Investor's Business Daily

2 months ago

BridgeBio Pharma Stock Earns 87 RS Rating

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?
CPRX

Zacks

3 months ago

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
CPRX

Investor's Business Daily

3 months ago

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals
CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
CPRX

Zacks

3 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
CPRX

Zacks

3 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Arcellx Stock Earns 82 Relative Strength Rating
CPRX

Investor's Business Daily

3 months ago

Arcellx Stock Earns 82 Relative Strength Rating

Neurocrine Biosciences Stock Sees RS Rating Upgrade
CPRX

Investor's Business Daily

3 months ago

Neurocrine Biosciences Stock Sees RS Rating Upgrade

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
CPRX

Zacks

3 months ago

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

CPRX

Argus Research

3 months ago

CPRX: What does Argus have to say about CPRX?

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
CPRX

Zacks

3 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

CPRX

Argus Research

3 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating
CPRX

Investor's Business Daily

4 months ago

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating

CPRX

Argus Research

4 months ago

CPRX: What does Argus have to say about CPRX?

Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?
CPRX

Zacks

4 months ago

Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?

CPRX

Argus Research

4 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
CPRX

Simply Wall St.

4 months ago

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
CPRX

Zacks

4 months ago

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
CPRX

Zacks

4 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List
CPRX

GlobeNewswire

4 months ago

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CPRX

GlobeNewswire

4 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
CPRX

Zacks

4 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point
CPRX

Simply Wall St.

5 months ago

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point

CPRX

Argus Research

5 months ago

CPRX: Raising target price to $24.00

Vericel Stock Sees RS Rating Shoot Higher
CPRX

Investor's Business Daily

5 months ago

Vericel Stock Sees RS Rating Shoot Higher

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
CPRX

GuruFocus.com

5 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case
CPRX

Simply Wall St.

5 months ago

With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case

Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?
CPRX

Zacks

5 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?

Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say
CPRX

Zacks

5 months ago

Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say

Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
CPRX

Zacks

5 months ago

Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates

CPRX

Associated Press Finance

5 months ago

Catalyst: Q3 Earnings Snapshot

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

CPRX vs. STVN: Which Stock Is the Better Value Option?
CPRX

Zacks

5 months ago

CPRX vs. STVN: Which Stock Is the Better Value Option?

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Report Preview: What To Look For
CPRX

GuruFocus.com

5 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Report Preview: What To Look For

CPRX

Argus Research

5 months ago

CPRX: What does Argus have to say about CPRX?

Are Medical Stocks Lagging Bioventus (BVS) This Year?
CPRX

Zacks

5 months ago

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CPRX or STVN: Which Is the Better Value Stock Right Now?
CPRX

Zacks

5 months ago

CPRX or STVN: Which Is the Better Value Stock Right Now?

High Growth Tech Stocks to Watch in October 2024
CPRX

Simply Wall St.

5 months ago

High Growth Tech Stocks to Watch in October 2024

With 75% ownership of the shares, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is heavily dominated by institutional owners
CPRX

Simply Wall St.

6 months ago

With 75% ownership of the shares, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is heavily dominated by institutional owners

CPRX

Argus Research

6 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

CPRX or STVN: Which Is the Better Value Stock Right Now?
CPRX

Zacks

6 months ago

CPRX or STVN: Which Is the Better Value Stock Right Now?

Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?
CPRX

Zacks

6 months ago

Catalyst (CPRX) Upgraded to Buy: What Does It Mean for the Stock?

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

High Growth Tech Stocks In The United States You Should Know
CPRX

Simply Wall St.

7 months ago

High Growth Tech Stocks In The United States You Should Know

Despite lower earnings than three years ago, Catalyst Pharmaceuticals (NASDAQ:CPRX) investors are up 293% since then
CPRX

Simply Wall St.

7 months ago

Despite lower earnings than three years ago, Catalyst Pharmaceuticals (NASDAQ:CPRX) investors are up 293% since then

Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?
CPRX

Zacks

7 months ago

Why Is Catalyst (CPRX) Up 8.3% Since Last Earnings Report?

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today
CPRX

Zacks

7 months ago

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today

CPRX

Argus Research

7 months ago

CPRX: Lowering target price to $21.00

CPRX

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 08/23/2024

Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating & Scientific Officer ...
CPRX

GuruFocus.com

7 months ago

Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating & Scientific Officer ...

CPRX

Argus Research

7 months ago

CPRX: Raising target price to $22.00

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CPRX

GlobeNewswire

7 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago
CPRX

Zacks

7 months ago

Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago

Wall Street Analysts See a 56.65% Upside in Catalyst (CPRX): Can the Stock Really Move This High?
CPRX

Zacks

7 months ago

Wall Street Analysts See a 56.65% Upside in Catalyst (CPRX): Can the Stock Really Move This High?

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Anemic Earnings Might Be Worse Than You Think
CPRX

Simply Wall St.

7 months ago

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Anemic Earnings Might Be Worse Than You Think

Catalyst (CPRX) Reports Q2 Earnings: What Key Metrics Have to Say
CPRX

Zacks

8 months ago

Catalyst (CPRX) Reports Q2 Earnings: What Key Metrics Have to Say

Catalyst Pharmaceutical (CPRX) Beats Q2 Earnings and Revenue Estimates
CPRX

Zacks

8 months ago

Catalyst Pharmaceutical (CPRX) Beats Q2 Earnings and Revenue Estimates

CPRX

Associated Press Finance

8 months ago

Catalyst: Q2 Earnings Snapshot

Share on Social Networks: